{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:17:30Z","timestamp":1776856650069,"version":"3.51.2"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008106","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000}}],"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1111658"],"award-info":[{"award-number":["OPP1111658"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1111658"],"award-info":[{"award-number":["OPP1111658"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["262686"],"award-info":[{"award-number":["262686"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["249979"],"award-info":[{"award-number":["249979"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007137","name":"Helse Nord RHF","doi-asserted-by":"publisher","award":["14796"],"award-info":[{"award-number":["14796"]}],"id":[{"id":"10.13039\/501100007137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1008106","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T15:33:21Z","timestamp":1597419201000},"page":"e1008106","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Drug-target binding quantitatively predicts optimal antibiotic dose levels in quinolones"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3738-3469","authenticated-orcid":true,"given":"Fabrizio","family":"Clarelli","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-7028","authenticated-orcid":true,"given":"Adam","family":"Palmer","sequence":"additional","affiliation":[]},{"given":"Bhupender","family":"Singh","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1254-1798","authenticated-orcid":true,"given":"Merete","family":"Storflor","sequence":"additional","affiliation":[]},{"given":"Silje","family":"Lauksund","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-7198","authenticated-orcid":true,"given":"Ted","family":"Cohen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-6989","authenticated-orcid":true,"given":"S\u00f6ren","family":"Abel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9420-9005","authenticated-orcid":true,"given":"Pia","family":"Abel zur Wiesch","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"issue":"9","key":"pcbi.1008106.ref001","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1164\/rccm.201407-1264OC","article-title":"A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis","volume":"191","author":"MJ Boeree","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"pcbi.1008106.ref002","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1542\/peds.105.2.e19","article-title":"The impact of dosing frequency on the efficacy of 10-day penicillin or amoxicillin therapy for streptococcal tonsillopharyngitis: A meta-analysis","volume":"105","author":"AJ Lan","year":"2000","journal-title":"Pediatrics"},{"issue":"12","key":"pcbi.1008106.ref003","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.40.12.2765","article-title":"Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections","volume":"40","author":"JJ Roord","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"pcbi.1008106.ref004","first-page":"560","article-title":"Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh","volume":"8","author":"A Van Deun","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"pcbi.1008106.ref005","unstructured":"WHO. The shorter MDR-TB regimen. http:\/\/wwwwhoint\/tb\/Short_MDR_regimen_factsheetpdf?ua=1. 2016."},{"issue":"9","key":"pcbi.1008106.ref006","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1715849","article-title":"Bacterial Factors That Predict Relapse after Tuberculosis Therapy","volume":"379","author":"R Colangeli","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"pcbi.1008106.ref007","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cid\/cir664","article-title":"Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin","volume":"53","author":"EJ Goldstein","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"9 Supplement","key":"pcbi.1008106.ref008","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1128\/JCM.00580-11","article-title":"The Clinical Predictive Value (or Lack Thereof) of the Results of In Vitro Antimicrobial Susceptibility Tests","volume":"49","author":"GV Doern","year":"2011","journal-title":"Journal of Clinical Microbiology"},{"issue":"9","key":"pcbi.1008106.ref009","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.clinthera.2016.06.015","article-title":"Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing","volume":"38","author":"NJ Onufrak","year":"2016","journal-title":"Clin Ther"},{"key":"pcbi.1008106.ref010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12866-016-0838-9","article-title":"Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae","volume":"16","author":"S Foerster","year":"2016","journal-title":"BMC Microbiol"},{"issue":"1794","key":"pcbi.1008106.ref011","first-page":"20140566","article-title":"The path of least resistance: aggressive or moderate treatment?","volume":"281","author":"RD Kouyos","year":"2014","journal-title":"Proc Biol Sci"},{"issue":"Suppl 2","key":"pcbi.1008106.ref012","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1073\/pnas.1100299108","article-title":"The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy","volume":"108","author":"AF Read","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pcbi.1008106.ref013","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10559","article-title":"How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance","volume":"4","author":"C Colijn","year":"2015","journal-title":"Elife"},{"issue":"5","key":"pcbi.1008106.ref014","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant selection window hypothesis updated","volume":"44","author":"K Drlica","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"7","key":"pcbi.1008106.ref015","doi-asserted-by":"crossref","first-page":"e1002158","DOI":"10.1371\/journal.ppat.1002158","article-title":"Selection of resistant bacteria at very low antibiotic concentrations","volume":"7","author":"E Gullberg","year":"2011","journal-title":"PLoS Pathog"},{"issue":"1","key":"pcbi.1008106.ref016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/dkg269","article-title":"The mutant selection window and antimicrobial resistance","volume":"52","author":"K Drlica","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"pcbi.1008106.ref017","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00407-012-0098-5","article-title":"The Hill equation and the origin of quantitative pharmacology","volume":"66","author":"R Gesztelyi","year":"2012","journal-title":"Arch Hist Exact Sci"},{"issue":"1","key":"pcbi.1008106.ref018","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41467-017-00716-z","article-title":"Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors","volume":"8","author":"DA Sykes","year":"2017","journal-title":"Nat Commun"},{"issue":"91","key":"pcbi.1008106.ref019","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002304","article-title":"A critical subset model provides a conceptual basis for the high antiviral activity of major HIV drugs","volume":"3","author":"L Shen","year":"2011","journal-title":"Sci Transl Med"},{"issue":"6","key":"pcbi.1008106.ref020","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nchembio.1796","article-title":"Translating slow-binding inhibition kinetics into cellular and in vivo effects","volume":"11","author":"GK Walkup","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"287","key":"pcbi.1008106.ref021","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa8760","article-title":"Classic reaction kinetics can explain complex patterns of antibiotic action","volume":"7","author":"P Abel zur Wiesch","year":"2015","journal-title":"Sci Transl Med"},{"issue":"10","key":"pcbi.1008106.ref022","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"KJ Aldred","year":"2014","journal-title":"Biochemistry"},{"issue":"2","key":"pcbi.1008106.ref023","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1073\/pnas.82.2.307","article-title":"Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA","volume":"82","author":"LL Shen","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"pcbi.1008106.ref024","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1021\/bi00435a039","article-title":"Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug\u2014DNA binding model","volume":"28","author":"LL Shen","year":"1989","journal-title":"Biochemistry"},{"key":"pcbi.1008106.ref025","first-page":"517","volume-title":"The quinolones","author":"VT Andriole","year":"2000","edition":"3"},{"key":"pcbi.1008106.ref026","first-page":"248","volume-title":"Antimicrobial resistance a crisis in health care","author":"American Society for Microbiology Eastern Pennsylvania Branch","year":"1995"},{"issue":"35","key":"pcbi.1008106.ref027","doi-asserted-by":"crossref","first-page":"22615","DOI":"10.1074\/jbc.273.35.22615","article-title":"The DNA gyrase-quinolone complex. ATP hydrolysis and the mechanism of DNA cleavage","volume":"273","author":"SC Kampranis","year":"1998","journal-title":"J Biol Chem"},{"key":"pcbi.1008106.ref028","first-page":"347","volume-title":"The New generation of quinolones","author":"C Siporin","year":"1990"},{"issue":"1","key":"pcbi.1008106.ref029","doi-asserted-by":"crossref","first-page":"e1005321","DOI":"10.1371\/journal.pcbi.1005321","article-title":"Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies","volume":"13","author":"P Abel Zur Wiesch","year":"2017","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"pcbi.1008106.ref030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1099\/00222615-23-1-83","article-title":"The response of Escherichia coli to ciprofloxacin and norfloxacin","volume":"23","author":"TS Elliott","year":"1987","journal-title":"J Med Microbiol"},{"issue":"4","key":"pcbi.1008106.ref031","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ja.2011.5","article-title":"Bacteriostatic versus bactericidal activity of ciprofloxacin in Escherichia coli assessed by flow cytometry using a novel far-red dye","volume":"64","author":"F Silva","year":"2011","journal-title":"J Antibiot (Tokyo)"},{"issue":"2","key":"pcbi.1008106.ref032","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/jac\/dkx375","article-title":"Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli","volume":"73","author":"L Garoff","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"pcbi.1008106.ref033","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/AAC.45.4.1126-1136.2001","article-title":"Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes","volume":"45","author":"MC Sulavik","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"pcbi.1008106.ref034","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1128\/AAC.48.10.3670-3676.2004","article-title":"Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens","volume":"48","author":"RR Regoes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"pcbi.1008106.ref035","first-page":"4296","article-title":"Opposing effects of target overexpression reveal drug mechanisms","volume":"5","author":"AC Palmer","year":"2014","journal-title":"Nat CommunPubMed Central PMCID"},{"key":"pcbi.1008106.ref036","author":"W Fontana","journal-title":"Lecture Notes: Continuous-Time Monte-Carlo of Reaction Systems"},{"issue":"8","key":"pcbi.1008106.ref037","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1128\/AAC.02463-14","article-title":"Antagonism between bacteriostatic and bactericidal antibiotics is prevalent","volume":"58","author":"PS Ocampo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 1","key":"pcbi.1008106.ref038","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj3010139","article-title":"Kinetics of penicillin binding to penicillin-binding proteins of Staphylococcus aureus","volume":"301","author":"HF Chambers","year":"1994","journal-title":"Biochem J"},{"issue":"Suppl 1","key":"pcbi.1008106.ref039","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/cid\/civ790","article-title":"Detection of a Novel gyrB Mutation Associated With Fluoroquinolone-Nonsusceptible Salmonella enterica serovar Typhimurium Isolated From a Bloodstream Infection in Ghana","volume":"62","author":"HM Al-Emran","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pcbi.1008106.ref040","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/eva.12202","article-title":"The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach","volume":"8","author":"T Vogwill","year":"2015","journal-title":"Evol Appl"},{"issue":"11","key":"pcbi.1008106.ref041","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/647952","article-title":"Antimicrobial susceptibility testing: a review of general principles and contemporary practices","volume":"49","author":"JH Jorgensen","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"pcbi.1008106.ref042","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1128\/AAC.42.9.2235","article-title":"Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis. The Baragwanath Ciprofloxacin Study Group","volume":"42","author":"J Lipman","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"10\u201311","key":"pcbi.1008106.ref043","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s002040050009","article-title":"Chondrotoxicity of ciprofloxacin in immature beagle dogs: immunohistochemistry, electron microscopy and drug plasma concentrations","volume":"73","author":"R Stahlmann","year":"2000","journal-title":"Arch Toxicol"},{"issue":"18","key":"pcbi.1008106.ref044","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1093\/nar\/gky793","article-title":"Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2","volume":"46","author":"A Hangas","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"pcbi.1008106.ref045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"MJ Waring","year":"2015","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"pcbi.1008106.ref046","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.08.001","article-title":"Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States","volume":"22","author":"BJ Metcalf","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"pcbi.1008106.ref047","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/jac\/dkx067","article-title":"WGS to predict antibiotic MICs for Neisseria gonorrhoeae","volume":"72","author":"DW Eyre","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pcbi.1008106.ref048","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"DJ Payne","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"pcbi.1008106.ref049","first-page":"372086","author":"BC van der Putten","year":"2018","journal-title":"Quantifying the contribution of four resistance mechanisms to ciprofloxacin minimum inhibitory concentration in Escherichia coli: a systematic review"},{"issue":"11","key":"pcbi.1008106.ref050","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/14740338.2019.1665022","article-title":"An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms\/dissections disseminated by the Food and Drug Administration and the European Medicines Agency","volume":"18","author":"AC Bennett","year":"2019","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"pcbi.1008106.ref051","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrd.2015.18","article-title":"The drug-target residence time model: a 10-year retrospective","volume":"15","author":"RA Copeland","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"pcbi.1008106.ref052","doi-asserted-by":"crossref","first-page":"948","DOI":"10.15252\/msb.20177723","article-title":"Drug detoxification dynamics explain the postantibiotic effect","volume":"13","author":"JK Srimani","year":"2017","journal-title":"Mol Syst Biol"},{"issue":"11","key":"pcbi.1008106.ref053","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamem.2012.05.027","article-title":"Mechanism for translocation of fluoroquinolones across lipid membranes","volume":"1818","author":"O Cramariuc","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"pcbi.1008106.ref054","volume-title":"Numerical computation of internal and external flows: introduction to the fundamentals of CFD","author":"C Hirsch","year":"2007"},{"issue":"19","key":"pcbi.1008106.ref055","doi-asserted-by":"crossref","first-page":"8488","DOI":"10.1093\/nar\/gkr553","article-title":"The dimer state of GyrB is an active form: implications for the initial complex assembly and processive strand passage","volume":"39","author":"J Wu","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1008106.ref056","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/msb.2011.38","article-title":"Quantification of mRNA and protein and integration with protein turnover in a bacterium","volume":"7","author":"T Maier","year":"2011","journal-title":"Mol Syst Biol"},{"issue":"7256","key":"pcbi.1008106.ref057","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature08184","article-title":"Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans","volume":"460","author":"J Malmstrom","year":"2009","journal-title":"Nature"},{"issue":"12","key":"pcbi.1008106.ref058","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.120163297","article-title":"One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products","volume":"97","author":"KA Datsenko","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pcbi.1008106.ref059","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/fty065","article-title":"Estimating treatment prolongation for persistent infections","volume":"76","author":"A Martinecz","year":"2018","journal-title":"Pathog Dis"},{"issue":"3","key":"pcbi.1008106.ref060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000238765","article-title":"Pharmacokinetics of sulbactam\/ampicillin in humans after intravenous and intramuscular injection","volume":"36","author":"S Ripa","year":"1990","journal-title":"Chemotherapy"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008106","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T13:41:24Z","timestamp":1598449284000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008106"}},"subtitle":[],"editor":[{"given":"Peter M.","family":"Kasson","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":60,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008106","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/369975","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]}}}